Garweg Justus Gerhard, Russ Christiane Elisabeth, Schellhorn Marc, Böhnke Matthias, Halberstadt Markus
Department of Ophthalmology, University of Bern, Inselspital, 3010 Bern, Switzerland.
Graefes Arch Clin Exp Ophthalmol. 2003 Sep;241(9):734-9. doi: 10.1007/s00417-003-0693-x. Epub 2003 Jun 21.
Little is known about the role of HSV-1 in keratitis not primarily attributed to herpetic origin. This study therefore aimed to prospectively evaluate the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis (experimental group: non-HSK) for the presence of HSV-1 antigens and DNA, and to compare the findings with those from individuals with typical herpetic stromal keratitis (positive control group: HSK) or non-inflammatory degenerative keratopathy (negative control group).
Corneal buttons derived from 51 patients with HSK, from 72 with non-HSK and from 30 with degenerative keratopathy were prospectively collected and subjected to immunohistochemical analysis for HSV-1 antigens and to HSV-1 DNA amplification.
In corneal buttons derived from patients with non-HSK, viral antigens were detected immunohistochemically in 8/72 cases and DNA amplified in 16/72. Corresponding values for the HSK group were 16/51 and 11/51. Taking viral antigen and DNA findings together, HSV-1 was detected in 18/72 (25%) patients with non-HSK and in 19/51 (37%) with HSK (p=0.2), but in only 2/30 (6%) individuals with non-inflammatory degenerative keratopathy.
Since the detection frequencies for HSV-1 antigens and DNA were comparable in the HSK and non-HSK groups, Herpes may play an underestimated and as yet undefined role in non-herpetic and clinically atypical herpetic stromal keratitis, either as a primary trigger of the disease or as a secondary contributor to it. In this category of individuals, early anti-herpetic therapy should be considered if patients do not respond in the expected manner to treatment for non-herpetic stromal keratitis.
关于单纯疱疹病毒1型(HSV-1)在并非主要由疱疹引起的角膜炎中的作用,人们了解甚少。因此,本研究旨在前瞻性评估非疱疹性或临床非典型疱疹性基质性角膜炎患者(实验组:非HSK)的角膜植片纽扣,检测其中HSV-1抗原和DNA的存在情况,并将结果与典型疱疹性基质性角膜炎患者(阳性对照组:HSK)或非炎性退行性角膜病患者(阴性对照组)的结果进行比较。
前瞻性收集了51例HSK患者、72例非HSK患者和30例退行性角膜病患者的角膜纽扣,进行HSV-1抗原的免疫组织化学分析和HSV-1 DNA扩增。
在非HSK患者的角膜纽扣中,免疫组织化学检测到病毒抗原的有8/72例,DNA扩增的有16/72例。HSK组的相应数值分别为16/51和11/51。综合病毒抗原和DNA检测结果,18/72(25%)例非HSK患者和19/51(37%)例HSK患者检测到HSV-1(p=0.2),而在非炎性退行性角膜病患者中仅2/30(6%)例检测到。
由于HSK组和非HSK组中HSV-1抗原和DNA的检测频率相当,疱疹在非疱疹性和临床非典型疱疹性基质性角膜炎中可能起着被低估且尚未明确的作用,可能是疾病的主要触发因素,也可能是次要促成因素。对于这类患者,如果对非疱疹性基质性角膜炎的治疗未出现预期反应,应考虑早期抗疱疹治疗。